1 In method comparison studies, FTDSARS-CoV-2 has shown 100% (91.8-100, 95% CI) diagnostic sensitivity and 100% (93.8-100, 95% CI) diagnostic specificity when tested in Copan eSwab nasopharyngeal and oropharyngeal swabs.
2 CE-IVD labelled for diagnostic use in the EU. For research use only (RUO) in the U.S. Pursuing FDA emergency use authorization (EUA) and WHO emergency use listing (EUL).
3 CE-IVD labelled for diagnostic use in the EU. For research use only (RUO) in the U.S.
4 Under development. Not available for sale. Future availability cannot be guaranteed.
Product availability varies by country and is subject to local regulatory requirements.